Powered By
SEROTONIN (5-HT) 1F RECEPTOR AGONIST
| The Reyvow brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Reyvow was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute migraine headaches with or without aura in adults. Reyvow was also known by its drug name, lasmiditan.
Reyvow was a serotonin (5-HT) 1F receptor agonist. They are believed to work by constricting blood vessels and reducing inflammation.
How was it taken?
Reyvow was taken as needed, up to 200 milligrams per day. Reyvow came in tablet form.
Side effects
The FDA-approved label for Reyvow listed common side effects including dizziness, fatigue, unusual sensations in the skin, and sleepiness.
Rare but serious side effects listed for Reyvow included serotonin syndrome, medication overuse headache, and central nervous syndrome depression.
For more details about this treatment, visit:
Become a member to get even more
Join
